The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2024.115163 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Jonas Saal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn (UKB), Germany; Institute of Experimental Onc…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Immune Checkpoint Inhibitors, Disease Progression. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, German Cancer Aid.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn (UKB), Germany; Institute of Experimental Oncology, University Hospital Bonn (UKB), Bonn, Germany; Center for Integ…
- Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Univer…
- Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany; Department of Urology, University Hospital Bonn (UKB), Bonn, Germany.
- Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn (UKB), Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
- Institute of Experimental Oncology, University Hospital Bonn (UKB), Bonn, Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
- Department for Urology University Hospital Essen, Germany; Department for Medical Oncology, University Hospital Essen, Germany.
Förderung
- University Hospital Bonn
- Rheinische Friedrich-Wilhelms-Universität Bonn
- German Cancer Aid
Zitieren
APA
Saal, J., Eckstein, M., Ritter, M., Brossart, P., Hölzel, M., Grünwald, V., & Klümper, N. (2025). The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.115163
Vancouver
Saal J, Eckstein M, Ritter M, Brossart P, Hölzel M, Grünwald V, et al. The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2024.115163
BibTeX
@article{Saal2025,
author = {Saal, Jonas and Eckstein, Markus and Ritter, Manuel and Brossart, Peter and Hölzel, Michael and Grünwald, Viktor and Klümper, Niklas},
title = {The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2024.115163}
}
EUVIMED